106 related articles for article (PubMed ID: 8568446)
21. [The characterization of influenza viruses by the immunoperoxidase method using monoclonal antibodies. Its setup and validation].
Oropesa Fernández S; Morier Díaz L; Vázquez Ramudo S; Goyenechea Hernández A; Valdivia Romero A; Hernández Espinosa B; García Infante S
Rev Cubana Med Trop; 1996; 48(3):149-54. PubMed ID: 9805039
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
23. Changes occurring on the cell surface during KSHV reactivation.
Whitman AG; Dyson OF; Lambert PJ; Oxendine TL; Ford PW; Akula SM
J Electron Microsc (Tokyo); 2007 Jan; 56(1):27-36. PubMed ID: 17392397
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
25. A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein.
Muraki Y; Murata T; Takashita E; Matsuzaki Y; Sugawara K; Hongo S
J Virol; 2007 Aug; 81(16):8766-73. PubMed ID: 17537859
[TBL] [Abstract][Full Text] [Related]
26. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
Roberts PC; Lamb RA; Compans RW
Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697
[TBL] [Abstract][Full Text] [Related]
27. Structural studies of the surface of virus-infected cells.
Dubois-Dalcq M; Rentier B
Prog Med Virol; 1980; 26():158-213. PubMed ID: 6999534
[No Abstract] [Full Text] [Related]
28. Advanced methods in electron microscopy of viruses.
Nermut MV
Lab Res Methods Biol Med; 1982; 5():1-58. PubMed ID: 6176827
[No Abstract] [Full Text] [Related]
29. Specificity of neuraminidase activity from influenza viruses isolated in different hosts tested with novel substrates.
Katinger D; Mochalova L; Chinarev A; Bovin N; Romanova J
Arch Virol; 2004 Nov; 149(11):2131-40. PubMed ID: 15503202
[TBL] [Abstract][Full Text] [Related]
30. [Analysis on the aetiology of influenza in children in Tianjin].
Guo XH; Duan WP; Wang SR; Zhang H; Li Y; Chen JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):19-21. PubMed ID: 12678956
[TBL] [Abstract][Full Text] [Related]
31. Ultrahigh-resolution scanning electron microscopy and its application to medical researches.
Tanaka K
Rhinol Suppl; 1992; 14():8-13. PubMed ID: 1382489
[TBL] [Abstract][Full Text] [Related]
32. Caprine arthritis encephalitis virus: evidence for a B/D-type assembly pathway in a C-type lentivirus replication.
Haziza B; Chauvin JP; Gluschankof P; Suzan M
Virology; 2001 Aug; 286(2):434-45. PubMed ID: 11485411
[TBL] [Abstract][Full Text] [Related]
33. The M1 matrix protein controls the filamentous phenotype of influenza A virus.
Elleman CJ; Barclay WS
Virology; 2004 Mar; 321(1):144-53. PubMed ID: 15033573
[TBL] [Abstract][Full Text] [Related]
34. Influenza circulating strains in Argentina exhibit differential induction of cytotoxicity and caspase-3 in vitro.
Mersich SE; Baumeister EG; Riva D; Lewis AP; Cadario ME; Pontoriero AV; Savy VL
J Clin Virol; 2004 Oct; 31(2):134-9. PubMed ID: 15364270
[TBL] [Abstract][Full Text] [Related]
35. In vitro growth profiles of respiratory syncytial virus in the presence of influenza virus.
Shinjoh M; Omoe K; Saito N; Matsuo N; Nerome K
Acta Virol; 2000 Apr; 44(2):91-7. PubMed ID: 10989700
[TBL] [Abstract][Full Text] [Related]
36. [RT-PCR for the determinationof the type of influenza virus circulating in the population].
Cisterna R; Meabe E
Rev Esp Quimioter; 2000 Sep; 13(3):286-90. PubMed ID: 11086279
[TBL] [Abstract][Full Text] [Related]
37. Mathematical model of influenza A virus production in large-scale microcarrier culture.
Möhler L; Flockerzi D; Sann H; Reichl U
Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163
[TBL] [Abstract][Full Text] [Related]
38. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
Tamura S; Kurata T
Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
[TBL] [Abstract][Full Text] [Related]
39. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
40. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
